The effect of cell penetrating peptides on transfection activity and cytotoxicity of polyallylamine

BioImpacts

Volumn 7, Issue 3, 2017, Pages 139-145

  Sabouri Rad, Sarvenaz ^a   Oskuee, Reza Kazemi ^b   Mahmoodi, Asma ^a   Gholami, Leila ^a   Malaekeh Nikouei, Bizhan ^c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell penetrating peptides; Polyallylamine; Polyplexes; Transfection

Indexed keywords

AMINE; CELL PENETRATING PEPTIDE; CYLOP 1 PEPTIDE; DNA; NANOPARTICLE; POLYALLYLAMINE; POLYMER; TAT PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHEMICAL PARAMETERS; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PLASMID; SYNTHESIS; ZETA POTENTIAL;

EID: 85031996282     PISSN: 22285652     EISSN: 22285660     Source Type: Journal    
DOI: 10.15171/bi.2017.17     Document Type: Article

References (38)

1. Sharma R, Khajuria R, Sharma C, Kapoor B, Goswami K, Kohli K. Gene therapy: Current concepts. JK Science 2004; 6:62-6.
2. Mehier-Humbert S, Guy RH. Physical methods for gene transfer: improving the kinetics of gene delivery into cells. Adv Drug Deliv Rev 2005; 57: 733-53. doi:10.1016/j.addr.2004.12.007
3. Rezaee M, Kazemi Oskuee R, Nassirli H, Malaekeh-Nikouei B. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems. J Control Release 2016; 236:1-14. doi: 10.1016/j.jconrel.2016.06.023
4. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009; 109: 259-302. doi: 10.1021/cr800409e
5. Boussif O, Zanta M, Behr J. Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther 1996; 3: 1074-80.
6. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release 2004; 94: 1-14. doi: 10.1016/j.jconrel.2003.09.013
7. Fischer D, Bieber T, Li Y, Elsässer H-P, Kissel T. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999; 16: 1273-79. doi: 10.1023/A:1014861900478
8. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-301.
9. Kwoh DY, Coffin CC, Lollo CP, Jovenal J, Banaszczyk MG, Mullen P, et al. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver. Biochim Biophys Acta 1999; 1444: 171-90. doi:10.1016/S0167-4781(98)00274-7
10. Chen DJ, Majors BS, Zelikin A, Putnam D. Structure-function relationships of gene delivery vectors in a limited polycation library. J Control Release 2005; 103: 273-83. doi:10.1016/j.jconrel.2004.11.028
11. Nimesh S, Kumar R, Chandra R. Novel polyallylamine-dextran sulfate-DNA nanoplexes: highly efficient non-viral vector for gene delivery. Int J Pharm 2006; 320: 143-49. doi:10.1016/j.ijpharm.2006.03.050
12. Munyendo WL, Lv H, Benza-Ingoula H, Baraza LD, Zhou J. Cell penetrating peptides in the delivery of biopharmaceuticals. Biomolecules 2012; 2: 187-202. doi:10.3390/biom2020187
13. Pooga M, Hällbrink M, Zorko M. Cell penetration by transportan. The FASEB J 1998; 12: 67-77.
14. Verma IM, Somia N. Gene therapy-promises, problems and prospects. Nature 1997; 389: 239-42. doi:10.1038/38410
15. Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997; 8: 1585-94. doi:10.1089/hum.1997.8.13-1585
16. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000; 18: 33-7. doi:10.1038/71889
17. Boussif O, Delair T, Brua C, Veron L, Pavirani A, Kolbe HV. Synthesis of polyallylamine derivatives and their use as gene transfer vectors in vitro. Bioconjug Chem 1999; 10: 877-83. doi:10.1021/bc9900439
18. Slita A, Kasyanenko N, Nazarova O, Gavrilova I, Eropkina E, Sirotkin A, et al. DNA-polycation complexes effect of polycation structure on physico-chemical and biological properties. J Biotechnol 2007; 127: 679-93. doi:10.1016/j.jbiotec.2006.07.016
19. Pathak A, Aggarwal A, Kurupati RK, Patnaik S, Swami A, Singh Y, et al. Engineered polyallylamine nanoparticles for efficient in vitro transfection. Pharm Res 2007; 24: 1427-40. doi:10.1007/s11095-007-9259-7
20. Gariépy J, Kawamura K. Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol 2001; 19: 21-8. doi: 10.1016/S0167-7799(00)01520-1
21. Zhang D, Wang J, Xu D. Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. J Control Release 2016; 229: 130-39. doi:10.1016/j.jconrel.2016.03.020
22. Trabulo S, Cardoso AL, Mano M, De Lima MCP. Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 2010; 3: 961-93. doi:10.3390/ph3040961
23. Järver P, Langel ü. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 2004; 9: 395-402. doi:10.1016/S1359-6446(04)03042-9.
24. Tünnemann G, Ter-Avetisyan G, Martin RM, Stöckl M, Herrmann A, Cardoso MC. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines. J Peptide Sci 2008; 14: 469-76. doi:10.1002/psc.968
25. Snyder EL, Dowdy SF. Cell penetrating peptides in drug delivery. Pharm Res 2004; 21: 389-93. doi:10.1023/B:PHAM.0000019289.61978.f5
26. Berry C. Intracellular delivery of nanoparticles via the HIV-1 tat peptide. Nanomedicine (Lond). 2008; 3:357-65. doi:10.1021/bi700416h
27. Jha D, Mishra R, Gottschalk S, Wiesmüller KH, Ugurbil K, Maier ME, Engelmann J. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes. Bioconjug Chem 2011; 22:319-28. doi:10.1021/bc100045s
28. Rungsardthong U, Ehtezazi T, Bailey L, Armes SP, Garnett MC, Stolnik S. Effect of polymer ionization on the interaction with DNA in nonviral gene delivery systems. Biomacromolecules 2003; 4: 683-90. doi:10.1021/bm025736y
29. Hu Y, Xu B, Ji Q, Shou D, Sun X, Xu J, et al. A mannosylated cell-penetrating peptide-graft-polyethylenimine as a gene delivery vector. Biomaterials 2014; 35: 4236-46. doi: 10.1186/s11671-016-1337-5
30. Rahmat D, Khan MI, Shahnaz G, Sakloetsakun D, Perera G, Bernkop-Schnürch A. Synergistic effects of conjugating cell penetrating peptides and thiomers on non-viral transfection efficiency. Biomaterials 2012; 33: 2321-26. doi:10.1016/j.biomaterials.2011.11.046
31. Rudolph C, Plank C, Lausier J, Schillinger U, Müller RH, Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 2003; 278: 11411-18. doi:10.1074/jbc.M211891200
32. Zaro JL, Shen W-C. Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun 2003; 307: 241-7. doi:10.1016/S0006-291X(03)01167-7
33. Ziegler A, Seelig J. Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters. Biophys J 2004; 86: 254-63. doi:10.1016/S0006-3495(04)74101-6
34. Tkachenko AG, Xie H, Liu Y, Coleman D, Ryan J, Glomm WR, et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 2004; 15: 482-90. doi:10.1021/bc034189q
35. Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 2004; 10:310-5. doi: 10.1038/nm996
36. Ferrari ME, Nguyen CM, Zelphati O, Tsai Y, Felgner PL. Analytical methods for the characterization of cationic lipid-nucleic acid complexes. Hum Gene Ther 1998; 9: 341-51. doi: 10.1089/hum.1998.9.3-341
37. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, Gait MJ, et al. Cell-penetrating peptides A reevaluation of the mechanism of cellular uptake. J Biol Chem 2003; 278: 585-90. doi:10.1074/jbc.M209548200
38. Brooks H, Lebleu B, Vivès E. Tat peptide-mediated cellular delivery: back to basics. Adv Drug Deliv Rev 2005; 57: 559-77. doi:10.1016/j.addr.2004.12.001